Cargando…

Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers

BACKGROUND: The question of a genetic contribution to the higher prevalence and incidence of end stage kidney disease (ESKD) among African Americans (AA) remained unresolved, until recent findings using admixture mapping pointed to the association of a genomic locus on chromosome 22 with this diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Shlush, Liran I, Bercovici, Sivan, Wasser, Walter G, Yudkovsky, Guennady, Templeton, Alan, Geiger, Dan, Skorecki, Karl
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975638/
https://www.ncbi.nlm.nih.gov/pubmed/20955568
http://dx.doi.org/10.1186/1755-8794-3-47
_version_ 1782190952113242112
author Shlush, Liran I
Bercovici, Sivan
Wasser, Walter G
Yudkovsky, Guennady
Templeton, Alan
Geiger, Dan
Skorecki, Karl
author_facet Shlush, Liran I
Bercovici, Sivan
Wasser, Walter G
Yudkovsky, Guennady
Templeton, Alan
Geiger, Dan
Skorecki, Karl
author_sort Shlush, Liran I
collection PubMed
description BACKGROUND: The question of a genetic contribution to the higher prevalence and incidence of end stage kidney disease (ESKD) among African Americans (AA) remained unresolved, until recent findings using admixture mapping pointed to the association of a genomic locus on chromosome 22 with this disease phenotype. In the current study we utilize this example to demonstrate the utility of applying a multi-step admixture mapping approach. METHODS: A multi-step case only admixture mapping study, consisted of the following steps was designed: 1) Assembly of the sample dataset (ESKD AA); 2) Design of the estimated mutual information ancestry informative markers (n = 2016) screening panel 3); Genotyping the sample set whose size was determined by a power analysis (n = 576) appropriate for the initial screening panel; 4) Inference of local ancestry for each individual and identification of regions with increased AA ancestry using two different ancestry inference statistical approaches; 5) Enrichment of the initial screening panel; 6) Power analysis of the enriched panel 7) Genotyping of additional samples. 8) Re-analysis of the genotyping results to identify a genetic risk locus. RESULTS: The initial screening phase yielded a significant peak using the ADMIXMAP ancestry inference program applying case only statistics. Subgroup analysis of 299 ESKD patients with no history of diabetes yielded peaks using both the ANCESTRYMAP and ADMIXMAP ancestry inference programs. The significant peak was found on chromosome 22. Genotyping of additional ancestry informative markers on chromosome 22 that took into account linkage disequilibrium in the ancestral populations, and the addition of samples increased the statistical significance of the finding. CONCLUSIONS: A multi-step admixture mapping analysis of AA ESKD patients replicated the finding of a candidate risk locus on chromosome 22, contributing to the heightened susceptibility of African Americans to develop non-diabetic ESKD, and underscores the importance of using mutual information and multiple ancestry inference approaches to achieve a robust analysis, using relatively small datasets of "affected" only individuals. The current study suggests solutions to some limitations of existing admixture mapping methodologies, such as considerations regarding the distribution of ancestry information along the genome and its effects on power calculations and sample size.
format Text
id pubmed-2975638
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29756382010-11-09 Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers Shlush, Liran I Bercovici, Sivan Wasser, Walter G Yudkovsky, Guennady Templeton, Alan Geiger, Dan Skorecki, Karl BMC Med Genomics Research Article BACKGROUND: The question of a genetic contribution to the higher prevalence and incidence of end stage kidney disease (ESKD) among African Americans (AA) remained unresolved, until recent findings using admixture mapping pointed to the association of a genomic locus on chromosome 22 with this disease phenotype. In the current study we utilize this example to demonstrate the utility of applying a multi-step admixture mapping approach. METHODS: A multi-step case only admixture mapping study, consisted of the following steps was designed: 1) Assembly of the sample dataset (ESKD AA); 2) Design of the estimated mutual information ancestry informative markers (n = 2016) screening panel 3); Genotyping the sample set whose size was determined by a power analysis (n = 576) appropriate for the initial screening panel; 4) Inference of local ancestry for each individual and identification of regions with increased AA ancestry using two different ancestry inference statistical approaches; 5) Enrichment of the initial screening panel; 6) Power analysis of the enriched panel 7) Genotyping of additional samples. 8) Re-analysis of the genotyping results to identify a genetic risk locus. RESULTS: The initial screening phase yielded a significant peak using the ADMIXMAP ancestry inference program applying case only statistics. Subgroup analysis of 299 ESKD patients with no history of diabetes yielded peaks using both the ANCESTRYMAP and ADMIXMAP ancestry inference programs. The significant peak was found on chromosome 22. Genotyping of additional ancestry informative markers on chromosome 22 that took into account linkage disequilibrium in the ancestral populations, and the addition of samples increased the statistical significance of the finding. CONCLUSIONS: A multi-step admixture mapping analysis of AA ESKD patients replicated the finding of a candidate risk locus on chromosome 22, contributing to the heightened susceptibility of African Americans to develop non-diabetic ESKD, and underscores the importance of using mutual information and multiple ancestry inference approaches to achieve a robust analysis, using relatively small datasets of "affected" only individuals. The current study suggests solutions to some limitations of existing admixture mapping methodologies, such as considerations regarding the distribution of ancestry information along the genome and its effects on power calculations and sample size. BioMed Central 2010-10-18 /pmc/articles/PMC2975638/ /pubmed/20955568 http://dx.doi.org/10.1186/1755-8794-3-47 Text en Copyright ©2010 Shlush et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shlush, Liran I
Bercovici, Sivan
Wasser, Walter G
Yudkovsky, Guennady
Templeton, Alan
Geiger, Dan
Skorecki, Karl
Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title_full Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title_fullStr Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title_full_unstemmed Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title_short Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
title_sort admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975638/
https://www.ncbi.nlm.nih.gov/pubmed/20955568
http://dx.doi.org/10.1186/1755-8794-3-47
work_keys_str_mv AT shlushlirani admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT bercovicisivan admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT wasserwalterg admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT yudkovskyguennady admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT templetonalan admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT geigerdan admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers
AT skoreckikarl admixturemappingofendstagekidneydiseasegeneticsusceptibilityusingestimatedmutualinformationancestryinformativemarkers